193
Participants
Start Date
December 31, 2011
Primary Completion Date
February 28, 2013
Study Completion Date
March 31, 2013
40 mg/mL Dexamethasone phosphate ophthalmic solution
Transscleral iontophoresis delivery of EGP-437 (dexamethasone phosphate formulated for ocular iontophoresis)
Prednisolone Acetate (1%) Eyedrops
Prednisolone acetate (1%) eyedrops
100 mM sodium citrate buffer solution
Transscleral iontophoresis delivery of 100 mM Sodium citrate buffer solution
Placebo Eyedrops
Placebo Eyedrops
The New York Eye and Ear Infirmary, New York
Scheie Eye Institute, Philadelphia
Mid-Atlantic Retina, Philadelphia
Wilmer Eye Institute, Baltimore
Virginia Eye Consultants, Norfolk
Charlotte Eye Ear Nose and Throat Associates, Matthews
Emory Eye Center, Atlanta
Advanced Eye Care, Fort Oglethorpe
Levenson Eye Associates, Jacksonville
Bascom Palmer Eye Institute, Miami
Logan Ophthalmic Research, Tamarac
The Eye Associates of Manatee, LLP, Bradenton
Department of Ophthalmology at University of Alabama at Birmingham, Birmingham
Southern College of Optometry, Memphis
Raj K. Maturi, M.D. PC, Indianapolis
Illinois Retina Associates, Chicago
Lifelong Vision Foundation, Chesterfield
Comprehensive Eye Care Ltd., Washington
Tauber Eye Center, Kansas City
Houston Eye Associates, Houston
Medical Center Ophthalmology Associates, San Antonio
Austin Retina Associates, Austin
Corneal Consultants of Colorado, Littleton
Colorado Retina Associates, Golden
Associated Retina Consultants, Phoenix
Arizona Eye Center, Chandler
Doheny Eye Medical Group, Los Angeles
Retina-Vitreous Associates Medical Group, Beverly Hills
Orange County Retina Medical Group, Santa Ana
Casey Eye Institute, Portland
Spokane Eye Clinical Research, Spokane
Connecticut Retina Consultants, LLC, Bridgeport
Eye Center of Southern Connecticut, Hamden
Yale Eye Center, New Haven
Ellsworth Uveitis and Retina Care, Ellsworth
Massachusetts Eye and Ear Infirmary, Boston
Ophthalmic Consultants of Boston, Boston
Massachusetts Eye Research and Surgery Institution, Cambridge
Metropolitan Eye Research and Surgery Institute, Palisades Park
Lead Sponsor
Eyegate Pharmaceuticals, Inc.
INDUSTRY